Age-based efficacy and safety of nivolumab for recurrent or metastatic head and neck squamous cell carcinoma: A multicenter retrospective study.
Takahito KondoIsaku OkamotoHiroki SatoNobuyuki KoyamaChihiro FushimiTakuro OkadaTatsuo MasubuchiKouki MiuraTakashi MatsukiTaku YamashitaGo OmuraHideaki TakahashiKiyoaki TsukaharaPublished in: Asia-Pacific journal of clinical oncology (2020)
There were no significant differences in OS, PFS, ORR, and DCR between the young and elderly groups. DCR tended to be better in the elderly group (P = 0.06). ILD occurred at a significantly higher rate in the young group.